Associated Papers
The Progress and Pitfalls of Pharmacogenetics-Based Precision Medicine in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis.
Teng Y et al.
Journal of Personalized Medicine, 2023
36983653 (PubMed )
Supplement: jpm-13-00471-s001.zip › Supplementary_Table_S1.xlsx › Table_S1
Pharmacogenetics and Schizophrenia-Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
Płaza O et al.
Biomedicines, 2022
Association of Polymorphisms within the Serotonin Receptor Genes 5-HTR1A, 5-HTR1B, 5-HTR2A and 5-HTR2C and Migraine Susceptibility in a Turkish Population.
Yücel Y et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology, 2016
Genetic variation and the risk of haloperidol-related parkinsonism in elderly patients: a candidate gene approach.
Knol W et al.
Journal of Clinical Psychopharmacology, 2013
Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.
Zhang JP et al.
Expert Opinion on Drug Metabolism & Toxicology, 2011
Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes.
Kring SI et al.
Plos One, 2009
Select a paper to view details